Cholesterol Med Recalled

A foreign tablet discovered in a bottle of fenofibrate tablets, USP, 145 mg (NDC 31722-596-90), has prompted Hetero Labs Limited to issue a voluntary recall for 5424 bottles of the cholesterol drug, according to the October 3, 2018, US Food and Drug Administration (FDA) Enforcement Report. A 500-mg valacyclovir tablet was found amid the fenofibrate tablets.

The recall affects 90-count bottles manufactured for Camber Pharmaceuticals from lot E181370 (Exp. 5/20). The recalled bottles were distributed in Indiana and Louisiana.

The recall was initiated by Hetero Labs Limited September 12, 2018. On September 25, 2018, the FDA designated the recall Class III. Under the recall classification, use of the affected tablets is not likely to cause harm.

Fenofibrate is a prescription drug used to treat high cholesterol and high triglyceride levels. Valacyclovir is a prescription antiviral used to treat herpes virus infections.

—Jolynn Tumolo

For more Pharmacy Learning Network articles, visit the homepage

To learn about Pharmacy Learning Network Live meetings, click here